Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial
| Main Authors: | , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
American Heart Association
2022
|
| _version_ | 1826312179083640832 |
|---|---|
| author | Preiss, D Herrington, W Haynes, R |
| author_facet | Preiss, D Herrington, W Haynes, R |
| author_sort | Preiss, D |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T08:23:37Z |
| format | Conference item |
| id | oxford-uuid:b929d28d-7d5b-48c3-aa60-81c40d5323ed |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T08:23:37Z |
| publishDate | 2022 |
| publisher | American Heart Association |
| record_format | dspace |
| spelling | oxford-uuid:b929d28d-7d5b-48c3-aa60-81c40d5323ed2024-02-06T13:43:50ZEmpagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trialConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:b929d28d-7d5b-48c3-aa60-81c40d5323edEnglishSymplectic ElementsAmerican Heart Association2022Preiss, DHerrington, WHaynes, R |
| spellingShingle | Preiss, D Herrington, W Haynes, R Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial |
| title | Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial |
| title_full | Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial |
| title_fullStr | Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial |
| title_full_unstemmed | Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial |
| title_short | Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial |
| title_sort | empagliflozin and cardiovascular outcomes in patients with chronic kidney disease the empa kidney trial |
| work_keys_str_mv | AT preissd empagliflozinandcardiovascularoutcomesinpatientswithchronickidneydiseasetheempakidneytrial AT herringtonw empagliflozinandcardiovascularoutcomesinpatientswithchronickidneydiseasetheempakidneytrial AT haynesr empagliflozinandcardiovascularoutcomesinpatientswithchronickidneydiseasetheempakidneytrial |